SponsorSponsor
  • USEF Network Paso Fino competition in Lexington is just about over tonight. The Paso's will return at 8am ET tomorrow morning 🐴🌞🎥📺 #PFHAGNS 9/30/2014 10:57:04 PM
  • USEF Network The @CapChallenge is over for the day. Stream continues tomorrow at 8am ET. WCHR Pro & Dev Pro Challenge Final rounds are tomorrow nigh 9/30/2014 9:27:11 PM
  • USEF Network Afternoon session at the @Paso_Fino_Horse Grand National Championship is over. Competition resumes at 6:35pm ET http://t.co/rJPFQqX5uS 9/30/2014 5:44:24 PM
  • HorseShowTutor let's see how fast I can get through the afternoon barn chores so I can get back to @CapChallenge live feed on @USEFNetwork ! Retweeted by USEFNetwork 9/30/2014 5:00:47 PM
  • USEF Network @monica_anne Don't cry. Make CapChallenge watching your study break reward :) Get 💯 and still see get your hunter fix :) 9/30/2014 4:00:50 PM
  • USEF Network Tuesday afternoon session of the @Paso_Fino_Horse Grand national Championship is live! http://t.co/zexACPWSsg 9/30/2014 3:08:30 PM
  • thesilentequestrian @USEFNetwork should really start a TV show Retweeted by USEFNetwork 9/30/2014 2:57:26 PM
  • Lauren Ashley My week consists of Capital Challenge & school & a horse show this weekend. Indoors consume my life. There goes my data plan.💁 @USE Retweeted by USEFNetwork 9/30/2014 2:57:05 PM
  • sara weener It's not a bad day at work with @USEFNetwork #capitalchallenge http://t.co/1cvzeJushe Retweeted by USEFNetwork 9/30/2014 2:56:57 PM
  • USEF Network @quietequestrian Hmm. What kind of show would you like to see, or should we be a whole channel ;) 9/30/2014 2:25:20 PM

News

USEF Approves Use of New NSAID Firocoxib Beginning August 1, 2007

RELEASE: July 2, 2007
AUTHOR/ADMINISTRATOR: gaillardm

(Lexington, KY) - The Board of Directors of the United States Equestrian Federation has approved the use of the new non-steroidal anti-inflammatory drug (NSAID) EQUIOXX® (firocoxib). This new NSAID is the first highly COX-1 sparing drug to be FDA approved for use in horses.

The rule allowing the use of firocoxib will take effect on 8/1/07. Until this time, the use of firocoxib is restricted to use outside competition.

The new rule lists firocoxib as a NSAID with a restrictive quantitative limit, and allows for a maximum permitted concentration of 0.240 micrograms per milliliter of blood plasma. The recommendation for appropriate dose and time consideration is to follow the manufacturer’s guidelines for its use at 0.1 milligram per kilogram of body weight once daily. This corresponds with a 45.5 milligram dose for a 1000 lb. horse, and should be given no sooner than 12 hours prior to competing. Firocoxib is permitted to be used for a period of 14 consecutive days.

Until further review by the FEI, per manufacturer recommendation firocoxib should not be used in a horse in the 30 days prior to competing in an FEI sanctioned event.

For more information contact Maria Partlow, Senior Vice President of Marketing and Communications, mpartlow@usef.org or (859) 225-6941




News

Competitions